Showing 1 - 10 of 120
Persistent link: https://www.econbiz.de/10008932851
congenital heart disease; £19,168 for infants with chronic lung disease; £3,845 for preterm infants < 29 wGA; £30,205 for preterm …, showing that palivizumab would be a cost-effective use of National Health Service resources. …
Persistent link: https://www.econbiz.de/10010185849
Persistent link: https://www.econbiz.de/10010160407
Persistent link: https://www.econbiz.de/10010146542
Persistent link: https://www.econbiz.de/10010147974
Persistent link: https://www.econbiz.de/10010148194
Persistent link: https://www.econbiz.de/10008430876
Persistent link: https://www.econbiz.de/10010159602
Persistent link: https://www.econbiz.de/10008932853
Persistent link: https://www.econbiz.de/10008276087